Annastasiah M. Mhaka, Ph.D.
Affiliations: | 2005 | Johns Hopkins University, Baltimore, MD |
Area:
Pharmacology, Pharmaceutical Chemistry, Cell BiologyGoogle:
"Annastasiah Mhaka"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Samuel R. Denmeade | grad student | 2005 | Johns Hopkins | |
| (Prostate specific membrane antigen (PSMA): A novel target for prostate cancer prodrug therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Denmeade SR, Mhaka AM, Rosen DM, et al. (2012) Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Science Translational Medicine. 4: 140ra86 |
| Denmeade SR, Mhaka AM, Rosen DM, et al. (2012) Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine) Science Translational Medicine. 4 |
| Singh P, Mhaka AM, Christensen SB, et al. (2005) Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase. Journal of Medicinal Chemistry. 48: 3005-14 |
| Mhaka A, Gady AM, Rosen DM, et al. (2004) Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA). Cancer Biology & Therapy. 3: 551-8 |
| Mhaka A, Denmeade SR, Yao W, et al. (2002) A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer. Bioorganic & Medicinal Chemistry Letters. 12: 2459-61 |